BioSpace News Archive

Avivagen Inc. is pleased to announce that it has received a new purchase order for OxC-beta Livestock from Industrias Melder in Mexico through Avivagen’s Mexican consultant Meyenberg International Group.

Next-generation Valve Designed to Reduce Paravalvular Leaking, Improve Procedural Efficiency and Treat More Patients with Expanded Indication over Prior Version

Infertility is a notable challenge world over and clomiphene citrate is a notable medication used to treat it in females.

The ehealth software and services market is rising at a stellar pace and is predicted to chart an impressive growth trajectory over the forecast period of 2019 to 2029.

Precision BioSciences, Inc., a clinical stage biotechnology company developing allogeneic CAR T and in vivo gene correction therapies with its ARCUS® genome editing platform, announced its participation in the following upcoming virtual investor conferences:

ILIAS Biologics Inc., a leading exosome-based therapeutics company, announced that the Company has completed a Series B financing round of $20.6 million in South Korea.

On September 25, 2020, BIORAY LABORATORIES Inc. announced for the first time that clinical trials of non-viral PD1 specific targeted CAR T therapy in relapsed/refractory B-cell non-Hodgkin lymphoma, undertaken by the company in cooperation with East China Normal University and the First Affiliated Hospital, School of Medicine, Zhejiang University, has achieved significant breakthroughs.

Initiating NURTEC ODT Phase 3 study for acute migraine in China and Korea, and China registrational study of troriluzole in Spinocerebellar Ataxia in 4Q20

Koneksa will invest in the continued development of its digital platform for integrating wearables, sensors, and other technologies on a global scale.

Manufacturers in the cholesterol lowering drugs market are increasing research activities to include bempedoic acid for the development of new drugs.